ATP also modulates tumor-associated immune response via the direct activation of inflammatory pathways [67] or causing immune suppression via the generation of its degradation product adenosine through CD39 and CD73 ectonucleotidase activation [68]. Here, ENTPD1 is linked to neoplasm.